1 MEDICAL/SURGICAL LASER UPDATE - American Society for ...

company will be best served by the joint efforts of all the shareholders. I look forward
to returning my focus to our restructuring efforts to enhance ESC's position in the
market."
Messrs. Genger and Gottstein stated, "We are gratified that we were able to amicably
resolve our differences with the Board of Directors. We, of course, recognize the
tremendous contribution made by Shimon Eckhouse and are pleased that he and the
current Board are willing to resolve the issues in a constructive manner. We think this
compromise will accelerate the company's ability to focus 100% of its energy to returning
the company to profitability and restoring shareholder value."
(The next meeting of the board of directors should be a doozy!)
6/23 Candela Corporation said that the Brazilian Ministry of Health has approved several of
its products for marketing in Brazil. Candela's president and CEO Gerard Puorro, said,
"Brazil is one of the world's largest markets for plastic surgery. We are optimistic that
our leading edge products will be well received by the over 16,000 dermatologists and
cosmetic surgeons who practice in Brazil." Candela's GentleLASE, ScleroPLUS and
ALEXLAZR have all been approved, and shipments of demonstration units will begin
immediately. In conjunction with its distribution partner, D.F. Vasconcellos S.A., the
company will develop a launch plan that will address the unique financing hurdles faced
by its customers to allow them to take full advantage of this opportunity.
6/23 American Dental Technologies announced that it had retained Tucker Anthony-Cleary
Gull to advise it in exploring strategic options to enhance shareholder value. "The
company has not made any decision as to any specific alternative and there can not be
any assurance that a transaction will result from this process," said Ben Gallant,
president and CEO.
6/23 According to Reuters, Singapore electronics and computer company Singatronics Ltd.
said it plans to divest its shareholdings in Candela Corp. It said in a statement the
proposed divestment was in conjunction with Candela's planned public offering of shares
in the third quarter of this year.
6/23 In a posting on the Yahoo message board, a chatter who had attended the Palomar
Medical Technologies annual meeting said that Mark Smith and his Monterey people did
not show, only a "hired gun" who wouldn't reply to any questions. The chatter went on
to say that Dan Valente's presentation was "terrific" and that at least 5 analysts were in
attendance. (So, perhaps, there will more coverage of the company?)
A few days later, another chatter reported that nobody yet knows who will be running the
company, as the official vote tally had not been completed. According to Palomar's
129